Abstract
Random-start COH has been reported as an alternative method for initiating oocyte/embryo cryopreservation cycles for the purpose of fertility preservation, with the benefit of a shortened interval from presentation to retrieval and thus to cancer treatment. We evaluated our experience with random start COH antagonist cycles, compared outcomes in luteal and non-luteal cycle starts, and measured the time from initial consultation to COH start.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
